NCT03592316

Brief Summary

The LEAP protocol is a prospective cohort study of dysvascular patients designed to determine whether implementation of a multi-disciplinary lower extremity amputation protocol in the peri-operative period can shorten post-operative length of stay in patients undergoing trans-tibial or trans-femoral amputations. A consecutive sample of patients diagnosed with peripheral vascular disease and/or diabetes requiring major lower extremity amputation will be enrolled in the study and compared to retrospective controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 10, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 19, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

November 14, 2018

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2020

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

February 12, 2021

Status Verified

February 1, 2021

Enrollment Period

1.4 years

First QC Date

July 10, 2018

Last Update Submit

February 10, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Hospital length of stay

    The total hospital length of stay for the lower extremity amputation admission

    Through hospital discharge, approximately 3 days after surgery

Secondary Outcomes (4)

  • Mortality

    Up to 6 months after surgery

  • Major adverse limb event

    Up to 6 months after surgery

  • In-hospital morbidity

    Through hospital discharge, approximately 3 days after surgery

  • Return to functional independence

    Up to 6 months after surgery

Study Arms (1)

Lower Extremity Amputation Pathway

EXPERIMENTAL

Patients will follow the Lower Extremity Amputation Pathway, which will include pre-operative consultations and earlier progression with physical therapy post-operatively.

Other: Lower Extremity Amputation Pathway

Interventions

Pre-operatively: Subjects will meet with social work/case management, physical therapy, anesthesiology, and the prosthetist for the following: discuss expectations and rehabilitation; pain control options and consideration for epidural or nerve block; prosthetic treatment and care timeline. Post-operatively: Physical therapy will begin on post-op day 1 with increasing complexity through post-op day 3. On post-op day 3 the wound will be examined by the surgeon and subjects will be cleared for discharge. Quality of life surveys will be given at several time points during post-operative care.

Lower Extremity Amputation Pathway

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients \>18 years of age diagnosed with peripheral vascular disease and/or diabetes mellitus
  • Patients undergoing trans-tibial or trans-femoral amputations

You may not qualify if:

  • Patients undergoing amputation for trauma, malignancy, or necrotizing fasciitis with no dysvascular diagnosis
  • Patients who have previously undergone an amputation
  • Patients who were unable to function independently prior to admission
  • Patients admitted to the ICU prior to surgery
  • Attending surgeon does not approve of the patient being enrolled
  • Prisoners
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Community Regional Medical Center

Fresno, California, 93721, United States

Location

Study Officials

  • Leigh Ann O'Banion, MD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2018

First Posted

July 19, 2018

Study Start

November 14, 2018

Primary Completion

March 31, 2020

Study Completion

December 31, 2020

Last Updated

February 12, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations